What is Januvia?

Januvia, also known as Sitagliptin, is a dipeptidyl peptidase-4 (DPP-4) inhibitor manufactured by Merck.  Januvia was introduced to the market in October of 2006 as a once-daily prescription drug used to treat those diagnosed with Type-2 diabetes.  If used in conjunction with proper diet and exercise it helps lower blood sugar levels in patients with type 2 diabetes.  However, shortly after it was introduced to the market, Januvia was linked to pancreatic disease such as cancer.

Additional Januvia FAQs

Featured Ashburn, VA Januvia Law Firm

Nager, Romaine & Schneiberg Co., L.P.A.

Our Attorneys Have the Skills, Experience and Knowledge to Provide You with Effective and Strong Representation that You Need and Deserve!
Available 24/7

Captcha Image

Ashburn Januvia Attorneys